Navigation Links
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Date:5/5/2009

site studies at the Apollo Hospital, Fortis Hospital, and Sigma New-Life Hospital in India. The studies enrolled end-stage renal disease (ESRD) patients infected with either HCV or HIV. In addition to establishing treatment safety, robust viral load reductions have been reported in both HCV and HIV infected individuals.

Research studies have also demonstrated the Hemopurifier(R) is effective in capturing a broad-spectrum of viruses untreatable with drug therapy, including several of world's deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever (DHF), Ebola hemorrhagic fever (EHF), Lassa hemorrhagic fever (LHF), H5N1 avian influenza (Bird Flu), the reconstructed 1918 influenza virus (r1918), West Nile virus (WNV), and Vaccinia and Monkeypox (MPV), which both serve as models for human smallpox infection. The studies were conducted with the assistance of researchers representing: The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID); The Centers for Disease Control and Prevention (CDC); The National Institute of Virology (NIV); The Battelle Biomedical Research Center (BBRC); and The Southwest Foundation for Biomedical Research (SFBR).

Beyond therapeutic market opportunities, Aethlon is leveraging principles underlying the Hemopurifier(R) technology platform to establish a pipeline of clinical and research diagnostic products and services. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

    Contacts:

    Dave Gentry or Jon Cunningham
    RedChip Companies Inc.
    (407) 644-4256
    (407) 491-4498 -cell
    Dave@redchip.com

    Jim Joyce
    Chairman, CEO
    858.459.7800 x301
    jj@aethlonmedical.com

    Jeff Richardson
    Senior Director, Comm
'/>"/>
SOURCE  Aethlon Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 

Related medicine news :

1. Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online
2. Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs
3. Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus
4. MSU engineering team designs innovative medical device
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
7. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
8. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
9. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
10. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
11. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... people from around the world have visited Israel,s Dead ... a reputation that dates back over 2000 years, and ... the introduction of two bath salt lines from SaltWorks ... of Dead Sea salt in their own homes. ,, ... salt and essential oils - but no artificial colors ...
(Date:12/16/2009)... Americans have myopia now than in the ,70s, study ... (nearsightedness) is more common in the United States than ... Eye Institute study shows. , Researchers compared National Health ... white participants from 1971 to 1972 and from 8,339 ... participants were 12 to 54 years old. , The ...
(Date:12/16/2009)... visitors can earn a free 21-count one week trial bottle sample ... ... MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com announces ... Sample” of Immune Response 247™ 6 Mushroom Formula , with ... Immune Response 247™ 6 Mushroom Formula is packaged in FDA approved ...
(Date:12/16/2009)... presented with the Weatherhead 100 Upstart Award on December 3, 2009. ... Ohio and is a testament to hard work, commitment, innovation and ... ... (PRWEB) December 16, 2009 -- Request A Test, Ltd. is proud ... December 3, 2009. The Weatherhead 100 showcases the fastest growing ...
(Date:12/16/2009)... be the perfect gift to give that special woman who has ... Licensed Esthetician Mary Schook introduces exceptional beauty products online while educating ... , ... (PRWEB) December 16, 2009 -- The holidays are ... that special woman who has everything? Why stem cells, of course!, ...
Breaking Medicine News(10 mins):Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2
... Lee Baca has justified placing Paris Hilton under house arrest ... seems that Judge Michael T Sauer who ordered her ... was conning doctors. ,On Larry Kings show, Larry Waldie, ... that Sauer didn't care, and that he even hinted that ...
... Many a families summer vacations mean piling into the car ... marred by frequent nausea and vomiting . This means some ... ,Carsickness, a variant of motion sickness, happens when the ... fast and in what direction the body is moving, says ...
... a clinical stage biopharmaceutical company developing targeted monoclonal ... C virus infection, today announced initiation of ... safety and efficacy of its tumor necrosis therapy ... (GBM), a deadly form of brain cancer. ...
... I trials studying REP8839, a novel topical antibiotic that ... skin pathogens including methicillin-resistant S. aureus (MRSA). ... topically applied REP8839 appears safe, well-tolerated and associated with ... which is desirable for a topical antibiotic treatment. Based ...
... Accera, Inc. announced today that recent data from its Phase ... AD may effectively be thought of and treated as diabetes ... to be caused by the accumulation of amyloid beta plaques ... shown that inducing insulin resistance in the brains of mice ...
... drug, Gatifloxacin, is a better treatment for drug- resistant ... a team of researchers led by Dr Buddha Basnyat ... ,As part of the study, researchers compared the effect ... recommended by the World Health Organisation for treating enteric ...
Other Medicine News:Health News:Car Sickness for the Little Ones can Be Prevented 2Health News:Car Sickness for the Little Ones can Be Prevented 3Health News:Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial 2Health News:Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839 2Health News:Experimental Drug Ketasyn(TM) (AC-1202) Treats Alzheimer's as Diabetes of the Brain 2
(Date:12/16/2009)... 16 , ... Microplasmin Recruits a Total of Over,640 patients ... ThromboGenics NV (Euronext Brussels: THR), a ... of innovative treatments for eye,disease, vascular disease ... completed,the enrolment of the second Phase III ...
(Date:12/15/2009)... Inc. (Nasdaq: BLUD ), a global leader in ... today announced that it will release its fiscal 2010 ... the market close. The Company will host a conference ... (Eastern Time) to discuss the results. ,, ... by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also access ...
(Date:12/15/2009)... -- Robbins & Myers, Inc. (NYSE: RBN ... its fiscal 2010 first quarter ending November 30, 2009, ... A live webcast is scheduled for ... Peter C. Wallace, President and Chief Executive Officer, ... Officer, will be discussing the Company,s performance and responding ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 1Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 2Aware Software and Development Services Enable State of the Art Fingerprint Card Scanning 10015 345 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 145 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 2Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2
... aqueous samples of moderate viscosity and density. Proven ergonomic design reduces hand ... Volume Range (ul) ... 1.0~2.0 Imprecision(%) ... 1 ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
Medicine Products: